Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis.
Essential oil from Pterodon emarginatus seeds ameliorates experimental autoimmune encephalomyelitis by modulating Th1/Treg cell balance.
Risk factors for increased multiple sclerosis susceptibility in the Iranian population.
Downregulation of cystathionine β-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type.
The multiple sclerosis drug fingolimod (FTY720) stimulates neuronal gene expression, axonal growth and regeneration.
A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.
Endovascular Treatment of Chronic Cerebro-Spinal Venous Insufficiency in Multiple Sclerosis: A retrospective study.
Contingent negative variation is associated with cognitive dysfunction and secondary progressive disease course in multiple sclerosis.
IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity.
Database integration of protocol-specific neurological imaging datasets.
Dissection of a Complex Disease Susceptibility Region Using a Bayesian Stochastic Search Approach to Fine Mapping.
Vestibular-evoked myogenic potentials, clinical evaluation, and imaging findings in multiple sclerosis.
FDA Drug Safety Communication: FDA investigating rare brain infection in patient taking Gilenya (fingolimod)
First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
Cutting Edge: MicroRNA-223 Regulates Myeloid Dendritic Cell-Driven Th17 Responses in Experimental Autoimmune Encephalomyelitis.
Quantitative assessment of upper limb motor function in Multiple Sclerosis using an instrumented Action Research Arm Test.
Information provision for people with multiple sclerosis.
Central Neuropathic Pain Syndromes.
Associations between Klinefelter's syndrome and autoimmune diseases: English national record linkage studies.
Brain Plasticity Effects of Neuromodulation Against Multiple Sclerosis Fatigue.
Human Umbilical Cord Stem Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Immunoinflammation and Remyelination.
A wireless body measurement system to study fatigue in multiple sclerosis.
Dibutyryl Cyclic AMP Inhibits the Progression of Experimental Autoimmune Encephalomyelitis and Potentiates Recruitment of Endogenous Neural Stem Cells.
Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice.
Pages
« first
‹ previous
…
324
325
326
327
328
329
330
331
332
…
next ›
last »